Proof of Concept Study of Re-treatment in BRVO With Ranibizumab Guided by OCT
Status:
Completed
Trial end date:
2016-12-20
Target enrollment:
Participant gender:
Summary
The aim of the trial is to evaluate the efficacy and safety of intravitreal injections of
ranibizumab for the treatment of macular edema due to BRVO if the re-treatment regimen is
guided by morphological macular changes detected by OCT compared to re-treatment according to
SmPC defined re-treatment criteria (in case of increase of CRT and concomitant decrease of
BCVA).